11 July 2023
|
Sami Hamid, Saddaf Hina, Ammar Alhasso, Paraskeve Granitsiotis
|
Functional Urology
Background The current treatment paradigm for detrusor overactivity (DO) and dysfunctional voiding (DV) includes conservative measures, pharmacotherapy, intravesical onabotulinum toxin A (Botox®), sacral nerve modulation (SNM / SNS) and urinary diversion as a last resort [1]. Incidence of DO is...